A venture capital firm headquartered in new York City focused on investing in healthcare and information technology companies.
Health Catalyst Capital Management is a venture capital firm that invests in healthcare IT businesses from the United States. The firm was founded by Charles Boorady in 2015, in New York, New York, United States.
The firm looks for companies that are filled with the potential to achieve $1 billion enterprise value, and to disrupt global markets. Health Catalyst Capital Management is interested in companies that provide big data platforms for musculoskeletal analysis, genomic sequencing, artificial intelligence driven platforms, health information exchange platforms, and APIs.
Health Catalyst Capital Management is a venture capital firmventure capital firm that invests in healthcare IT businesses from the United States. The firm was founded by Charles Boorady in 2015, in New York, New York, United States.
Health Catalyst Capital Management is a venture capital firm that invests in healthcare IT businesses from the United States. The firm was founded by Charles Boorady in 2015, in New YorkNew York, New York, United States.
The firm looks for companies that are filled with the potential to achieve $1 billion enterprise value, and to disrupt global markets. Health Catalyst Capital Management is interested in companies that provide big data platforms for musculoskeletal analysis, genomic sequencing, artificial intelligence driven platforms, health information exchange platforms, and APIs.
Health Catalyst Capital Management is a venture capital firm that invests in healthcare IT businesses from the United StatesUnited States. The firm was founded by Charles Boorady in 2015, in New York, New York, United States.
Health Catalyst Capital Management is a venture capital firm that invests in healthcare IT businesses from the United States. The firm was founded by Charles Boorady in 2015, in New York, New York, United States.
The firm looks for companies that are filled with the potential to achieve $1 billion enterprise value, and to disrupt global markets.